Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Inv. presentation
|
|
BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/01/2022 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 03/28/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/23/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/22/2022 |
4
| Watson W. Mark (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 90,663 shares
@ $0
Disposed/sold 22,685 restricted stock units
@ $0
Disposed/sold 54,740 options to buy
@ $2.93, valued at
$160.4k
Disposed/sold 85,760 options to buy
@ $3.66, valued at
$313.9k
|
|
| 03/22/2022 |
4
| Vollins James (See Remarks) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed/sold 91,401 restricted stock units
@ $0
Disposed/sold 29,826 options to buy
@ $3.46, valued at
$103.2k
Disposed/sold 43,334 options to buy
@ $3.9, valued at
$169k
Disposed/sold 269,244 options to buy
@ $3.84, valued at
$1M
Disposed/sold 82,508 options to buy
@ $3.03, valued at
$250k
Disposed/sold 282,055 options to buy
@ $3.66, valued at
$1M
|
|
| 03/22/2022 |
4
| Singh Vanila (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 35,851 shares
@ $0
Disposed/sold 17,019 restricted stock units
@ $0
Disposed/sold 81,008 options to buy
@ $4.36, valued at
$353.2k
Disposed/sold 48,000 options to buy
@ $3.76, valued at
$180.5k
Disposed/sold 85,760 options to buy
@ $3.66, valued at
$313.9k
|
|
| 03/22/2022 |
4
| Smith Thomas B (Chief Medical Officer) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 52,530 shares
@ $0
Disposed/sold 88,719 restricted stock units
@ $0
Disposed/sold 117,691 options to buy
@ $2.93, valued at
$344.8k
Disposed/sold 130,000 options to buy
@ $3.9, valued at
$507k
Disposed/sold 287,194 options to buy
@ $3.84, valued at
$1.1M
Disposed/sold 259,186 options to buy
@ $3.66, valued at
$948.6k
|
|
| 03/22/2022 |
4
| Sirgo Mark A (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 1,166,866 shares
@ $0
Disposed/sold 11,685 restricted stock units
@ $0
Disposed/sold 22,500 options to buy
@ $4.96, valued at
$111.6k
Disposed/sold 48,000 options to buy
@ $4.36, valued at
$209.3k
Disposed/sold 48,000 options to buy
@ $3.76, valued at
$180.5k
Disposed/sold 85,760 options to buy
@ $3.66, valued at
$313.9k
|
|
| 03/22/2022 |
4
| Plesha Scott M. (See Remarks) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 345,127 shares
@ $0
Disposed/sold 119,228 restricted stock units
@ $0
Disposed/sold 245,000 options to buy
@ $3.9, valued at
$955.5k
Disposed/sold 348,222 options to buy
@ $3.9, valued at
$1.4M
Disposed/sold 369,721 options to buy
@ $3.66, valued at
$1.4M
|
|
| 03/22/2022 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 7,588,395 shares
@ $0
Disposed/sold 22,685 restricted stock units
@ $0
Disposed/sold 7,500 options to buy
@ $2.93, valued at
$22k
Disposed/sold 85,760 options to buy
@ $3.66, valued at
$313.9k
|
|
| 03/22/2022 |
4
| Golubieski John (See Remarks) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed/sold 126,199 restricted stock units
@ $0
Disposed/sold 333,133 options to buy
@ $4.05, valued at
$1.3M
Disposed/sold 373,533 options to buy
@ $3.66, valued at
$1.4M
|
|
| 03/22/2022 |
4
| Greenleaf Peter (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 105,034 shares
@ $0
Disposed/sold 27,746 restricted stock units
@ $0
Disposed/sold 64,164 options to buy
@ $2.93, valued at
$188k
Disposed/sold 114,347 options to buy
@ $3.66, valued at
$418.5k
|
|
| 03/22/2022 |
4
| Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 252,207 shares
@ $0
Disposed/sold 22,685 restricted stock units
@ $0
Disposed/sold 48,123 options to buy
@ $2.93, valued at
$141k
Disposed/sold 85,760 options to buy
@ $3.66, valued at
$313.9k
|
|
| 03/22/2022 |
4
| Bailey Jeffrey Allen (CEO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 105,133 shares
@ $0
Disposed/sold 316,919 restricted stock units
@ $0
Disposed/sold 96,000 options to buy
@ $5.18, valued at
$497.3k
Disposed/sold 160,000 options to buy
@ $4.23, valued at
$676.8k
Disposed/sold 66,805 options to buy
@ $4.36, valued at
$291.3k
Disposed/sold 840,000 options to buy
@ $3.6, valued at
$3M
Disposed/sold 1,143,467 options to buy
@ $3.66, valued at
$4.2M
|
|
| 03/22/2022 |
8-K
| Resignation/termination of a director |
| 03/22/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/21/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/21/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/11/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/11/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/11/2022 |
4
| Bailey Jeffrey Allen (CEO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 5,333 restricted stock units
@ $0 |
|
| 03/09/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/04/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/04/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/24/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/24/2022 |
SC 13G
| Versor Investments LP reports a 5.1% stake in BioDelivery Sciences International, Inc. |
| 02/18/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/18/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 02/18/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 02/15/2022 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 02/15/2022 |
8-K/A
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulat... |
| 02/15/2022 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Converted 2,422,222 shares
@ $1.8, valued at
$4.4M
Converted 436 convertible preferred
@ $1.8, valued at
$784.8 |
|
|
|
|